Genetic drift can dominate short-term human immunodeficiency virus type 1 nef quasispecies evolution in vivo

Journal of Virology

Volumn 71, Issue 6, 1997, Pages 4233-4240

  Plikat, Uwe ^a   Nieselt Struwe, Kay ^b   Meyerhans, Andreas ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b MAX PLANCK INSTITUTE FOR BIOPHYSICAL CHEMISTRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 9; NEF PROTEIN; VIRUS DNA;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; EVOLUTION; GENETIC DRIFT; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LYMPHOCYTE COUNT; MOLECULAR CLONING; MONONUCLEAR CELL; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; PROVIRUS; SPECIES;

EID: 0030980281     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.6.4233-4240.1997     Document Type: Article

References (92)

1. Baier, M., M. T. Dittmar, K. Cichutek, and R. Kurth. 1991. Development in vivo of genetic variability of simian immunodeficiency virus. Proc. Natl. Acad. Sci. USA 88:8126-8130.
2. Baier, M., A. Werner, N. Bannert, K. Metzner, and R. Kurth. 1995. HIV suppression by interleukin-16. Nature 378:563.
3. Balfe, P., P. Simmonds, C. A. Ludlam, J. O. Bishop, and A. J. L. Brown. 1990. Concurrent evolution of human immunodeficiency virus type 1 in patients infected from the same source: rate of sequence change and low frequency of inactivating mutations. J. Virol. 64:6221-6233.
4. Bandelt, H.-J., and A. W. M. Dress. 1992. Split decomposition: a new and useful approach to phylogenetic analysis of distance data. Mol. Phylogenet. Evol. 1:242-252.
5. Blumberg, B. M., L. G. Epstein, Y. Saito, D. Chen, L. R. Sharer, and R. Anand. 1992. Human immunodeficiency virus type 1 nef quasispecies in pathological tissue. J. Virol. 66:5256-5264.
6. Bonhoeffer, S., E. C. Holmes, and M. A. Nowak. 1995. Causes of HIV diversity. Nature 376:125.
7. + cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J. Virol. 68:6103-6110.
8. Burns, D. P. W., and R. C. Desrosiers. 1991. Selection of genetic variants of simian immunodeficiency virus in persistently infected rhesus monkeys. J. Virol. 65:1843-1854.
9. Cheynier, R., S. Henrichwark, F. Hadida, E. Pelletier, E. Oksenhendler, B. Autran, and S. Wain-Hobson. 1994. Clonal expansion of T cells and HIV genotypes in microdissected splenic white pulps indicates viral replication in situ and infiltration of HIV-specific cytotoxic T lymphocytes. Cell 78:373-387.
10. Cheynier, R. Personal communication.
11. Cichutek, K., H. Merget, S. Norley, R. Linde, W. Kreuz, M. Gahr, and R. Kurth. 1992. Development of a quasispecies of human immunodeficiency virus type 1 in vivo. Proc. Natl. Acad. Sci. USA 89:7365-7369.
12. Cocchi, F., A. L. DeVico, A. Garzino-Demo, S. K. Arya, R. C. Gallo, and P. Lusso. 1995. Identification of RANTES, MIP-1α and MIP-1β as the major HIV-suppressive factors produced by CD8+ T cells. Science 270:1811-1815.
13. Coffin, J. M. 1992. Genetic diversity and evolution of retroviruses. Curr. Top. Microbiol. Immunol. 176:143-164.
14. Cullen, B. R. 1994. The role of Nef in the replication cycle of the human and simian immunodeficiency viruses. Virology 205:1-6.
15. Culmann, B., E. Gomard, M. P. Kieny, B. Guy, F. Dreyfus, A. G. Saimot, D. Sereni, D. Sicard, and J. P. Levy. 1991. Six epitopes reacting with human cytotoxic CD8+ T cells in the central region of the HIV-1 NEF protein. J. Immunol. 146:1560-1565.
16. Daniel, M. D., F. Kirchhoff, S. C. Czajak, P. K. Sehgal, and R. C. Desrosiers. 1992. Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science 258:1938-1941.
17. Delassus, S., R. Cheynier, and S. Wain-Hobson. 1991. Evolution of human immunodeficiency virus type 1 nef and long terminal repeat sequences over 4 years in vivo and in vitro. J. Virol. 65:225-231.
18. Delassus, S., R. Cheynier, and S. Wain-Hobson. 1992. Nonhomogeneous distribution of human immunodeficiency virus type 1 proviruses in the spleen. J. Virol. 66:5642-5645.
19. Dopazo, J., A. Dress, and A. von Haeseler. 1993. Split decomposition: a technique to analyze viral evolution. Proc. Natl. Acad. Sci. USA 90:10320-10324.
20. Du, Z., S. M. Lang, V. G. Sasseville, A. A. Lackner, P. O. Ilyinskii, M. D. Daniel, J. U. Jung, and R. C. Desrosiers. 1995. Identification of a nef allele that causes lymphocyte activation and acute disease in macaque monkeys. Cell 82:665-674.
21. Duarte, E. A., I. S. Novella, S. C. Weaver, E. Domingo, S. Wain-Hobson, D. K. Clarke, A. Moya, S. F. Elena, J. C. de la Torre, and J. J. Holland. 1994. RNA virus quasispecies: significance for viral disease and epidemiology. Infect. Agents Dis. 3:201-214.
22. Embretson, J., M. Zupancic, J. L. Ribas, A. Burke, P. Racz, K. Tenner Racz, and A. T. Haase. 1993. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 362: 359-362.
23. Felsenstein, J. 1993. Phylogeny Interference Package, version 3.5. Department of Genetics, University of Washington, Seattle.
24. Gao, F., L. Yue, A. T. White, P. G. Pappas, J. Barchue, A. P. Hanson, B. M. Greene, P. M. Sharp, G. M. Shaw, and B. H. Hahn. 1992. Human infection by genetically diverse SIVsm-related HIV-2 in West Africa. Nature 358:495-499.
25. Gowda, S. D., B. S. Stein, N. Mohagheghpour, C. J. Benike, and E. G. Engleman. 1989. Evidence that T cell activation is required for HIV-1 entry in CD4+ lymphocytes. J. Immunol. 142:773-780.
26. Guidotti, L. G., T. Ishikawa, M. V. Hobbs, B. Matzke, R. Schreiber, and F. V. Chisari. 1996. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 4:25-36.
27. Hadida, F., A. Parrot, M. P. Kieny, B. Sadat-Sowti, C. Mayaud, P. Debre. and B. Autran. 1992. Carhoxy-terminal and central regions of human immunodeficiency virus-1 Nef recognized by cytotoxic T lymphocytes from lymphoid organs. An in vitro limiting dilution analysis. J. Clin. Invest. 89:53-60.
28. Higgins, D. G., and P. M. Sharp. 1989. Fast and sensitive multiple sequence alignments on a microcomputer. Comput. Appl. Biosci. 5:151-153.
29. Ho, D. D. 1992. HIV-1 viraemia and influenza. Lancet 339:1549.
30. Ho, D. D., A. U. Neumann, A. S. Perelson, W. Chen, J. M. Leonard, and M. Markowitz. 1995. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373:123-126.
31. Holland, J. J., J. C. de la Torre, and D. A. Steinhauer. 1992. RNA virus populations as quasispecies. Curr. Top. Microbiol. Immunol. 176:1-20.
32. Holmes, E. C., L. Q. Zhang, P. Simmonds, C. A. Ludlam, and A. J. Brown. 1992. Convergent and divergent sequence evolution in the surface envelope glycoprotein of human immunodeficiency virus type 1 within a single infected patient. Proc. Natl. Acad. Sci. USA 89:4835-4839.
33. Howell, R. M., J. E. Fitzgibbon, M. Noe, Z. J. Ren, D. J. Gocke, T. A. Schwartzer, and D. T. Dubin. 1991. In vivo sequence variation of the human immunodeficiency virus type 1 env gene: evidence for recombination among variants found in a single individual. AIDS Res. Hum. Retroviruses 7:869-876.
34. Huang, Y., L. Zhang, and D. D. Ho. 1995. Characterization of nef sequences in long-term survivors of human immunodeficiency virus type 1 infection. J. Virol. 69:93-100.
35. Hughes, A. L., and M. Nei. 1988. Pattern of nucleotide substitution at major histocompatibility complex class I loci reveals overdominant selection. Nature 335:167-170.
36. Hughes, A. L., and M. Nei. 1989. Nucleotide substitution at major histocompatibility complex class II loci: evidence for overdominant selection. Proc. Natl. Acad. Sci. USA 86:958-962.
37. Huson, D. H., and R. Wetzel. SplitsTree version 1.0.1. FSP Mathematisierung, University of Bielefeld, Bielefeld, Germany.
38. Johnson, P. R., T. E. Hamm, S. Goldstein, S. Kitov, and V. M. Hirsch. 1991. The genetic fate of molecularly cloned simian immunodeficiency virus in experimentally infected macaques. Virology 185:217-228.
39. Kestler, H. W., D. J. Ringler, K. Mori, D. L. Panicali, P. K. Sehgal, M. D. Daniel, and R. C. Desrosiers. 1991. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65:651-662.
40. Kimura, M. 1981. Estimation of evolutionary distances between homologous nucleotide sequences. Proc. Natl. Acad. Sci. USA 78:454-458.
41. Koenig, S., T. R. Fuerst, L. V. Wood, R. M. Woods, J. A. Suzich, G. M. Jones, V. F. de la Cruz, R. T. J. Davey, S. Venkatesan, B. Moss, et al. 1990. Mapping the fine specificity of a cytolytic T cell response to HIV-1 nef protein. J. Immunol. 145:127-135.
42. Koup, R. A., J. T. Safrit, Y. Cao, C. A. Andrews, G. McLeod, W. Borkowsky, C. Farthing, and D. D. Ho. 1994. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68:4650-4655.
43. Lamhamedi Cherradi, S., B. Culmann Penciolelli, B. Guy, M. P. Kieny, F. Dreyfus, A. G. Saimot, D. Sereni, D. Sicard, J. P. Levy, and E. Gomard. 1992. Qualitative and quantitative analysis of human cytotoxic T-lymphocyte responses to HIV-1 proteins. AIDS 6:1249-1258.
44. Larder, B. A. 1994. Interactions between drug resistance mutations in human immunodeficiency virus type 1 reverse transcriptase. J. Gen. Virol. 75:951-957.
45. Leigh Brown, A. J., and A. Cleland. 1996. Independent evolution of the env and pol genes of HIV-1 during zidovudine therapy. AIDS 10:1067-1073.
46. Lucchiari, M., G. Niedermann, C. Leipner, A. Meyerhans, K. Eichmann, and B. Maier. 1994. Human immune response to HIV-1-nef. I. CD45RO-T lymphocytes of non-infected donors contain cytotoxic T lymphocyte precursors at high frequencies. Int. Immunol. 6:1739-1749.
47. Maggi, E., F. Annunziato, R. Manetti, R. Biagiotti, M. G. Giudizi, A. Ravina, F. Almerigogna, N. Boiani, M. Alderson, and S. Romagnani. 1995. Activation of HIV expression by CD30 triggering in CD4+ T cells from HIV-infected individuals. Immunity 3:251-255.
48. Mansky, L. M., and H. M. Temin. 1995. Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. J. Virol. 69:5087-5094.
49. Martinez, M. A., V. Pezo, P. Marliere, and S. Wain-Hobson. 1996. Exploring the robustness of an enzyme by in vitro evolution. EMBO J. 15:1203-1210.
50. Martins, L. P., N. Chenciner, B. Åsjö, A. Meyerhans, and S. Wain-Hobson. 1991. Independent fluctuation of human immunodeficiency virus type 1 rev and gp41 quasispecies in vivo. J. Virol. 65:4502-4507.
51. McNearney, T., Z. Hornickova, A. Templeton, A. Birdwell, M. Arens, R. Markham, A. Saah, and L. Ratner. 1995. Nef and LTR sequence variation from sequentially derived human immunodeficiency virus type 1 isolates. Virology 208:388-398.
52. Meyerhans, A., R. Cheynier, J. Albert, M. Seth, S. Kwok, J. Sninsky, L. Morfeldt-Manson, B. Asjö, and S. Wain-Hobson. 1989. Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations. Cell 58:901-910.
53. Meyerhans, A., G. Dadaglio, J. P. Vartanian, P. Langlade-Demoyen, R. Frank, B. Asjö, F. Plata, and S. Wain-Hobson. 1991. In vivo persistence of a HIV-1-encoded HLA-B27-restricted cytotoxic T lymphocyte epitope despite specific in vitro reactivity. Eur. J. Immunol. 21:2637-2640.
54. Moore, J. P., and D. D. Ho. 1995. HIV-1 neutralization: the consequences of viral adaptation to growth on transformed T cells. AIDS 9:S117-S136.
55. Nixon, D. F., and A. J. McMichael. 1991. Cytotoxic T-cell recognition of HIV proteins and peptides. AIDS 5:1049-1059.
56. Novella, I. S., S. F. Elena, A. Moya, E. Domingo, and J. J. Holland. 1995. Size of genetic bottlenecks leading to virus fitness loss is determined by mean initial population fitness. J. Virol. 69:2869-2872.
57. Nowak, M. A., R. M. Anderson, A. R. McLean, T. F. Wolfs, J. Goudsmit, and R. M. May. 1991. Antigenic diversity thresholds and the development of AIDS. Science 254:963-969.
58. Nowak, M. A., R. M. May, R. E. Phillips, S. Rowland-Jones, D. G. Lalloo, S. McAdam, P. Klenerman, B. Koeppe, K. Sigmund, C. R. M. Bangham, and A. J. McMichael. 1995. Antigenic oscillations and shifting immunodominance in HIV-1 infections. Nature 375:606-611.
59. O'Brien, W. A., K. Grovit-Ferbas, A. Namazi, S. Ovcak-Derzic, H. J. Wang, J. Park, C. Yeramian, S. H. Mao, and J. A. Zack. 1995. Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination. Blood 86:1082-1089.
60. Overbaugh, J., L. M. Rudensey, M. D. Papenhausen, R. E. Benveniste, and W. R. Morton. 1991. Variation in simian immunodeficiency virus env is confined to V1 and V4 during progression to simian AIDS. J. Virol. 65: 7025-7031.
61. Pang, S., Y. Shlesinger, E. S. Daar, T. Moudgil, D. D. Ho, and I. S. Chen. 1992. Rapid generation of sequence variation during primary HIV-1 infection. AIDS 6:453-460.
62. Pantaleo, G., C. Graziosi, J. F. Demarest, L. Butini, M. Montroni, C. H. Fox, J. M. Orenstein, D. P. Kotler, and A. S. Fauci. 1993. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 362:355-358.
63. Pedroza-Martins, L., N. Chenciner, and S. Wain-Hobson. 1992. Complex intrapatient sequence variation in the V1 and V2 hypervariable regions of the HIV-1 gp 120 envelope sequence. Virology 191:837-845.
64. Pelletier, E., W. Saurin, R. Cheynier, N. L. Letvin, and S. Wain-Hobson. 1995. The tempo and mode of SIV quasispecies development in vivo calls for massive viral replication and clearance. Virology 208:644-652.
65. Perelson, A. S., A. U. Neumann, M. Markowitz, J. M. Leonard, and D. D. Ho. 1996. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 271:1582-1586.
66. Perry, S. T., M. T. Flaherty, M. J. Kelley, D. L. Clabough, S. R. Tronick, L. Coggins, L. Whetter, C. R. Lengel, and F. Fuller. 1992. The surface envelope protein gene region of equine infectious anemia virus is not an important determinant of tropism in vitro. J. Virol. 66:4085-4097.
67. Phillips, R. E., S. Rowland-Jones, D. F. Nixon, F. M. Gotch, J. P. Edwards, A. O. Ogunlesi, J. G. Elvin, J. A. Rothbard, C. R. Bangham, C. R. Rizza, and A. J. McMichael. 1991. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature 354:453-459.
68. Ratner, L., and T. M. J. Niederman. 1995. Nef. Curr. Top. Microbiol. Immunol. 193:169-208.
69. Sala, M., E. Pelletier, and S. Wain-Hobson. 1995. HIV-1 gp120 sequences from a doubly infected drug user. AIDS Res. Hum. Retroviruses 11:653-655.
70. Sala, M., G. Zambruno, J.-P. Vartanian, A. Marconi, U. Bertazzoni, and S. Wain-Hobson. 1994. Spatial discontinuities in human immunodeficiency virus type 1 quasispecies derived from epidermal Langerhans cells of a patient with AIDS and evidence for double infection. J. Virol. 68:5280-5283.
71. Sánchez-Palomino, S., J. M. Rojas, M. A. Martinez, E. M. Fenyö, R. Nájera, E. Domingo, and C. López-Galíndez. 1993. Dilute passage promotes expression of genetic and phenotypic variants of human immunodeficiency virus type 1 in cell culture. J. Virol. 67:2938-2943.
72. Schnittman, S. M., H. C. Lane, J. Greenhouse, J. S. Justement, M. Baseler, and A. S. Fauci. 1990. Preferential infection of CD4+ memory T cells by human immunodeficiency virus type 1: evidence for a role in the selective T-cell functional defects observed in infected individuals. Proc. Natl. Acad. Sci. USA 87:6058-6062.
73. Schuitemaker, H., N. A. Kootsfra, R. A. Fouchier, B. Hooibrink, and F. Miedema. 1994. Productive HIV-1 infection of macrophages restricted to the cell fraction with proliferate capacity. EMBO J. 13:5929-5936.
74. Shugars, D. C., M. S. Smith, D. H. Glueck, P. V. Nantermet, F. Seillier-Moiseiwitsch, and R. Swanstrom. 1993. Analysis of human immunodeficiency virus type 1 nef gene sequences present in vivo. J. Virol. 67:4639-4650.
75. Simmonds, P., L. Q. Zhang, F. McOmish, P. Balfe, C. A. Ludlam, and A. J. L. Brown. 1991. Discontinuous sequence change of human immunodeficiency virus (HIV) type 1 env sequences in plasma viral and lymphocyte-associated proviral populations in vivo: implications for models of HIV pathogenesis. J. Virol. 65:6266-6276.
76. Staprans, S. I., B. L. Hamilton, S. E. Follansbee, T. Elbeik, P. Barbosa, R. M. Grant, and M. B. Feinberg. 1995. Activation of virus replication after vaccination of HIV-1-infected individuals. J. Exp. Med. 182:1727-1737.
77. Steuler, H., B. Storch-Hagenlocher, and B. Wildemann. 1992. Distinct populations of human immunodeficiency virus lype 1 in blood and cerebrospinal fluid. AIDS Res. Hum. Retroviruses 8:53-59.
78. Tsunetsugu-Yokota, Y., K. Akagawa, H. Kimoto, K. Suzuki, M. Iwasaki, S. Yasuda, G. Häusser, C. Hultgren, A. Meyerhans, and T. Takemori. 1995. Monocyte-derived cultured dendritic cells are susceplihle to human immunodeficiency virus infection and transmit virus to resting T cells in the process of nominal antigen presentation. J. Virol. 69:4544-4547.
79. Udaka, K., K.-H. Wiesmueller, S. Kienle, G. Jung, and P. Walden. 1995. Decrypting the structure of major histocompatibility complex class I-restricted cytotoxic T lymphocyte epitopes with complex peptide libraries. J. Exp. Med. 181:2097-2108.
80. Vartanian, J.-P., A. Meyerhans, B. Åsjö, and S. Wain-Hobson. 1991. Selection, recombination, and G→A hypermutation of human immunodeficiency virus type 1 genomes. J. Virol. 65:1779-1788.
81. Venet, A., and B. D. Walker. 1993. Cytotoxic T-cell epitopes in HIV/SIV infection. AIDS 7(Suppl. 1):S117-S126.
82. Wain-Hobson, S., P. Sonigo, M. Guyader, A. Gazit, and M. Henry. 1995. Erratic G-A hypermutation within a complete caprine arthritis-encephalitis virus (CAEV) provirus. Virology 209:297-303.
83. Walker, C. M., D. J. Moody, D. P. Stites, and J. A. Levy. 1986. CD8+ lymphocytes can control HIV replication in vitro by suppressing virus replication. Science 234:1563-1566.
84. Wei, X., S. K. Ghosh, M. E. Taylor, V. A. Johnson, E. A. Emini, P. Deutsch, J. D. Lifson, S. Bonhoeffer, M. A. Nowak, B. H. Hahn, M. S. Saag, and G. M. Shaw. 1995. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373:117-122.
85. Weidt, G., W. Deppert, O. Utermöhlen, J. Heukeshoven, and F. Lehmann-Grube. 1995. Emergence of virus escape mutants after immunization with epitope vaccine. J. Virol. 69:7147-7151.
86. Weissman, D., T. D. Barker, and A. S. Fauci. 1996. The efficiency of acute infection of CD4+ T cells is markedly enhanced in the setting of antigen-specific immune activation. J. Exp. Med. 183:687-692.
87. Wolfs, T. F., G. Zwart, M. Bakker, M. Valk, C. L. Kuiken, and J. Goudsmit. 1991. Naturally occurring mutations within HIV-1 V3 gcnomic RNA lead to antigenic variation dependent on a single amino acid substitution. Virology 185:195-205.
88. Wolinsky, S. M., B. T. Korber, A. U. Neumann, M. Daniels, K. J. Kunstman, A. J. Whetsell, M. R. Furtado, Y. Cao, D. D. Ho, J. T. Safrit, and R. A. Koup. 1996. Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection. Science 272:537-542.
89. + lymphocyte response in acutely infected rhesus monkeys. J. Virol. 67:1707-1711.
90. Zhang, L. Q., P. MacKenzie, A. Cleland, E. C. Holmes, A. J. L. Brown, and P. Simmonds. 1993. Selection for specific sequences in the external envelope prolein of human immunodeficiency virus type 1 upon primary infection. J. Virol. 67:3345-3356.
91. Zhu, T., H. Mo, N. Wang, D. S. Nam, Y. Cao, R. A. Koup, and D. D. Ho. 1993. Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Science 261:1179-1181.
92. Zhu, T., N. Wang, A. Carr, S. Wolinsky, and D. D. Ho. 1995. Evidence for coinfection by multiple strains of human immunodeficiency virus type 1 subtype B in an acute seroconvertor. J. Virol. 69:1324-1327.